Mild magnetic hyperthermia is synergistic with an antibiotic treatment against dual species biofilms consisting of S. aureus and P. aeruginosa by enhancing metabolic activity

References

• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi: 10.1126/science.284.5418.1318.
   PubMed Web of Science ®Google Scholar
• James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16(1):37–44. doi: 10.1111/j.1524-475X.2007.00321.x.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi: 10.1128/CMR.15.2.167-193.2002.
   PubMed Web of Science ®Google Scholar
• Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677–701. doi: 10.1146/annurev.micro.57.030502.090720.
   PubMed Web of Science ®Google Scholar
• Dowd SE, Wolcott RD, Sun Y, et al. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded flx amplicon pyrosequencing (btefap). PLoS One. 2008;3(10):e3326. doi: 10.1371/journal.pone.0003326.
   PubMed Web of Science ®Google Scholar
• Tipton CD, Mathew ME, Wolcott RA, et al. Temporal dynamics of relative abundances and bacterial succession in chronic wound communities. Wound Repair Regen. 2017;25(4):673–679. doi: 10.1111/wrr.12555.
   PubMed Web of Science ®Google Scholar
• Omar A, Wright JB, Schultz G, et al. Microbial biofilms and chronic wounds. Microorganisms. 2017;5(1):9. doi: 10.3390/microorganisms5010009.
   PubMed Web of Science ®Google Scholar
• Kim MH, Yamayoshi I, Mathew S, et al. Magnetic nanoparticle targeted hyperthermia of cutaneous staphylococcus aureus infection. Ann Biomed Eng. 2013;41(3):598–609. doi: 10.1007/s10439-012-0698-x.
   PubMed Web of Science ®Google Scholar
• Alumutairi L, Yu B, Filka M, et al. Mild magnetic nanoparticle hyperthermia enhances the susceptibility of staphylococcus aureus biofilm to antibiotics. Int J Hyperthermia. 2020;37(1):66–75. doi: 10.1080/02656736.2019.1707886.
   PubMed Web of Science ®Google Scholar
• Ricker EB, Nuxoll E. Synergistic effects of heat and antibiotics on pseudomonas aeruginosa biofilms. Biofouling. 2017;33(10):855–866. doi: 10.1080/08927014.2017.1381688.
   PubMed Web of Science ®Google Scholar
• Sturtevant RA, Sharma P, Pavlovsky L, et al. Thermal augmentation of vancomycin against staphylococcal biofilms. Shock. 2015;44(2):121–127. doi: 10.1097/SHK.0000000000000369.
   PubMed Web of Science ®Google Scholar
• Percival SL, McCarty SM, Lipsky B. Biofilms and wounds: an overview of the evidence. Adv Wound Care (New Rochelle). 2015;4(7):373–381. doi: 10.1089/wound.2014.0557.
   PubMed Web of Science ®Google Scholar
• Buch PJ, Chai Y, Goluch ED. Treating polymicrobial infections in chronic diabetic wounds. Clin Microbiol Rev. 2019;32(2):e00091–18. doi: 10.1128/CMR.00091-18.
   PubMed Web of Science ®Google Scholar
• Gjodsbol K, Christensen JJ, Karlsmark T, et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006;3(3):225–231. doi: 10.1111/j.1742-481X.2006.00159.x.
   PubMedGoogle Scholar
• Puca V, Marulli RZ, Grande R, et al. Microbial species isolated from infected wounds and antimicrobial resistance analysis: data emerging from a three-years retrospective study. Antibiotics (Basel). 2021;10(10):1162. doi: 10.3390/antibiotics10101162.
   PubMed Web of Science ®Google Scholar
• Schaumburg F, Vas Nunes J, Monnink G, et al. Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility. Infection. 2022;50(4):907–914. doi: 10.1007/s15010-022-01762-6.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang L, Alm M, et al. Enhanced antibiotic tolerance of an in vitro multispecies uropathogen biofilm model, useful for studies of catheter-associated urinary tract infections. Microorganisms. 2022;10(6):1207. doi: 10.3390/microorganisms10061207.
   PubMed Web of Science ®Google Scholar
• O'Brien TJ, Figueroa W, Welch M. Decreased efficacy of antimicrobial agents in a polymicrobial environment. Isme J. 2022;16(7):1694–1704. doi: 10.1038/s41396-022-01218-7.
   PubMed Web of Science ®Google Scholar
• Nabb DL, Song S, Kluthe KE, et al. Polymicrobial interactions induce multidrug tolerance in staphylococcus aureus through energy depletion. Front Microbiol. 2019;10:2803. doi: 10.3389/fmicb.2019.02803.
   PubMed Web of Science ®Google Scholar
• Macdonald KE, Boeckh S, Stacey HJ, et al. The microbiology of diabetic foot infections: a meta-analysis. BMC Infect Dis. 2021;21(1):770. doi: 10.1186/s12879-021-06516-7.
   PubMed Web of Science ®Google Scholar
• Trizna EY, Yarullina MN, Baidamshina DR, et al. Bidirectional alterations in antibiotics susceptibility in staphylococcus aureus-pseudomonas aeruginosa dual-species biofilm. Sci Rep. 2020;10(1):14849. doi: 10.1038/s41598-020-71834-w.
   PubMed Web of Science ®Google Scholar
• Woods PW, Haynes ZM, Mina EG, et al. Maintenance of s. Aureus in co-culture with p. Aeruginosa while growing as biofilms. Front Microbiol. 2018;9:3291. doi: 10.3389/fmicb.2018.03291.
   PubMed Web of Science ®Google Scholar
• Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–1755. doi: 10.1086/647952.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC, Samaras T, Yarmolenko PS, et al. Cem43 degrees c thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol. 2013;23(8):2215–2227. doi: 10.1007/s00330-013-2825-y.
   PubMed Web of Science ®Google Scholar
• Kong C, Chee CF, Richter K, et al. Suppression of staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, um-c162. Sci Rep. 2018;8(1):2758. doi: 10.1038/s41598-018-21141-2.
   PubMed Web of Science ®Google Scholar
• Seth AK, Geringer MR, Hong SJ, et al. Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo, rabbit ear model. PLoS One. 2012;7(8):e42897. doi: 10.1371/journal.pone.0042897.
   PubMed Web of Science ®Google Scholar
• Fleury B, Kelley WL, Lew D, et al. Transcriptomic and metabolic responses of staphylococcus aureus exposed to supra-physiological temperatures. BMC Microbiol. 2009;9:76. doi: 10.1186/1471-2180-9-76.
   PubMed Web of Science ®Google Scholar
• Tomlinson BR, Malof ME, Shaw LN. A global transcriptomic analysis of staphylococcus aureus biofilm formation across diverse clonal lineages. Microb Genom. 2021;7:000598.
   PubMed Web of Science ®Google Scholar
• Bertrand BP, Heim CE, West SC, et al. Role of staphylococcus aureus formate metabolism during prosthetic joint infection. Infect Immun. 2022;90(11):e0042822. doi: 10.1128/iai.00428-22.
   PubMed Web of Science ®Google Scholar
• Kenny JG, Ward D, Josefsson E, et al. The staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One. 2009;4(2):e4344. doi: 10.1371/journal.pone.0004344.
   PubMed Web of Science ®Google Scholar
• Han SO, Inui M, Yukawa H. Transcription of corynebacterium glutamicum genes involved in tricarboxylic acid cycle and glyoxylate cycle. J Mol Microbiol Biotechnol. 2008;15(4):264–276. doi: 10.1159/000117614.
   PubMed Web of Science ®Google Scholar
• Stokes JM, Lopatkin AJ, Lobritz MA, et al. Bacterial metabolism and antibiotic efficacy. Cell Metab. 2019;30(2):251–259. doi: 10.1016/j.cmet.2019.06.009.
   PubMed Web of Science ®Google Scholar
• Martinez JL, Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):768–789. doi: 10.1111/j.1574-6976.2011.00282.x.
   PubMed Web of Science ®Google Scholar
• Walters MC 3rd, Roe F, Bugnicourt A, et al. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47(1):317–323. doi: 10.1128/AAC.47.1.317-323.2003.
   PubMed Web of Science ®Google Scholar
• Mariscal A, Lopez-Gigosos RM, Carnero-Varo M, et al. Fluorescent assay based on resazurin for detection of activity of disinfectants against bacterial biofilm. Appl Microbiol Biotechnol. 2009;82(4):773–783. doi: 10.1007/s00253-009-1879-x.
   PubMed Web of Science ®Google Scholar
• Dalecki AG, Crawford CL, Wolschendorf F. Targeting biofilm associated staphylococcus aureus using resazurin based drug-susceptibility assay. J Vis Exp. 2016;
   PubMed Web of Science ®Google Scholar
• Masadeh MM, Alzoubi KH, Ahmed WS, et al. In vitro comparison of antibacterial and antibiofilm activities of selected fluoroquinolones against pseudomonas aeruginosa and methicillin-resistant staphylococcus aureus. Pathogens. 2019;8(1):12. doi: 10.3390/pathogens8010012.
   PubMed Web of Science ®Google Scholar
• Zhao G, Hochwalt PC, Usui ML, et al. Delayed wound healing in diabetic (db/db) mice with pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen. 2010;18(5):467–477. doi: 10.1111/j.1524-475X.2010.00608.x.
   PubMed Web of Science ®Google Scholar
• Mastropaolo MD, Evans NP, Byrnes MK, et al. Synergy in polymicrobial infections in a mouse model of type 2 diabetes. Infect Immun. 2005;73(9):6055–6063. doi: 10.1128/IAI.73.9.6055-6063.2005.
   PubMed Web of Science ®Google Scholar
• Kok M, Maton L, van der Peet M, et al. Unraveling antimicrobial resistance using metabolomics. Drug Discov Today. 2022;27(6):1774–1783. doi: 10.1016/j.drudis.2022.03.015.
   PubMed Web of Science ®Google Scholar
• Gazel D, Demirbakan H, Erinmez M. In vitro activity of hyperthermia on swarming motility and antimicrobial susceptibility profiles of proteus mirabilis isolates. Int J Hyperthermia. 2021;38(1):1002–1012. doi: 10.1080/02656736.2021.1943546.
   PubMed Web of Science ®Google Scholar
• Su YB, Peng B, Li H, et al. Pyruvate cycle increases aminoglycoside efficacy and provides respiratory energy in bacteria. Proc Natl Acad Sci U S A. 2018;115: E1578–E1587.
   PubMed Web of Science ®Google Scholar
• Meylan S, Porter CBM, Yang JH, et al. Carbon sources tune antibiotic susceptibility in pseudomonas aeruginosa via tricarboxylic acid cycle control. Cell Chem Biol. 2017;24(2):195–206. doi: 10.1016/j.chembiol.2016.12.015.
   PubMed Web of Science ®Google Scholar
• Gaupp R, Lei S, Reed JM, et al. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype. Antimicrob Agents Chemother. 2015;59(7):4226–4238. doi: 10.1128/AAC.00160-15.
   PubMed Web of Science ®Google Scholar